Connect with us

Digital Health

CoachCare Acquires Verustat to Expand Remote Patient Monitoring Reach

What You Should Know: – CoachCare, a leading remote patient monitoring (RPM) and virtual health company, has made its fourth acquisition in 12 months,…

Published

on

This article was originally published by HIT Consultant

What You Should Know:

CoachCare, a leading remote patient monitoring (RPM) and virtual health company, has made its fourth acquisition in 12 months, snapping up Nashville-based Verustat for an undisclosed amount.

– This strategic move further strengthens CoachCare’s position in the rapidly growing RPM market, projected to reach $175.2 billion by 2027.

Strengthening Focus on Chronic Conditions

Founded in 2020, Verustat brings valuable expertise in primary care and cardiology, areas plagued by prevalent chronic conditions like hypertension, obesity, and diabetes. CoachCare already excels in supporting patients with these conditions, and Verustat’s addition further solidifies their leadership position.

“We have gotten to know the Verustat team and their approach to remote care aligns well with CoachCare,” said Wes Haydon, President and Co-Founder of CoachCare. “We are pleased to welcome their clients and staff to CoachCare and to continue growing our best-in-class remote care platform.”

Acquisition Impact for CoachCare

The strategic acquisition positions CoachCare to deliver even greater value to both patients and healthcare providers. Patients benefit from a comprehensive remote care solution that addresses their specific needs, while providers gain access to Verustat’s expertise and CoachCare’s extensive resources. This win-win combination paves the way for improved patient outcomes, increased provider revenue, and a more efficient healthcare system overall.

remote patient monitoring

Digital Health

Keep it Short

By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading
Digital Health

Seattle startup Olamedi building platform to automate health clinic communications

A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…

Continue Reading

Trending